vs

Side-by-side financial comparison of RB GLOBAL INC. (RBA) and ResMed (RMD). Click either name above to swap in a different company.

ResMed is the larger business by last-quarter revenue ($1.4B vs $1.2B, roughly 1.2× RB GLOBAL INC.). ResMed runs the higher net margin — 27.6% vs 9.1%, a 18.5% gap on every dollar of revenue. On growth, ResMed posted the faster year-over-year revenue change (11.0% vs 5.4%). Over the past eight quarters, ResMed's revenue compounded faster (7.9% CAGR vs 6.3%).

Ritchie Bros. Auctioneers (RBA), or simply Ritchie Bros., is a publicly traded company legally domiciled in Canada with headquarters in Westchester, Illinois. Its common shares are traded on the Toronto Stock Exchange and the New York Stock Exchange.

ResMed Inc. is a medical equipment company based in San Diego, California, and founded in Australia. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea, chronic obstructive pulmonary disease (COPD), and other respiratory conditions. Resmed produced hundreds of thousands of ventilators and bilevel devices to help treat the respiratory symptoms of patients with COVID-19.

RBA vs RMD — Head-to-Head

Bigger by revenue
RMD
RMD
1.2× larger
RMD
$1.4B
$1.2B
RBA
Growing faster (revenue YoY)
RMD
RMD
+5.6% gap
RMD
11.0%
5.4%
RBA
Higher net margin
RMD
RMD
18.5% more per $
RMD
27.6%
9.1%
RBA
Faster 2-yr revenue CAGR
RMD
RMD
Annualised
RMD
7.9%
6.3%
RBA

Income Statement — Q4 FY2025 vs Q4 FY2026

Metric
RBA
RBA
RMD
RMD
Revenue
$1.2B
$1.4B
Net Profit
$109.7M
$392.6M
Gross Margin
61.8%
Operating Margin
14.7%
34.6%
Net Margin
9.1%
27.6%
Revenue YoY
5.4%
11.0%
Net Profit YoY
-7.4%
13.9%
EPS (diluted)
$0.53
$2.68

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
RBA
RBA
RMD
RMD
Q2 26
$1.4B
Q4 25
$1.2B
$1.4B
Q3 25
$1.1B
$1.3B
Q2 25
$1.2B
$1.3B
Q1 25
$1.1B
$1.3B
Q4 24
$1.1B
$1.3B
Q3 24
$981.8M
$1.2B
Q2 24
$1.1B
$1.2B
Net Profit
RBA
RBA
RMD
RMD
Q2 26
$392.6M
Q4 25
$109.7M
$392.6M
Q3 25
$95.5M
$348.5M
Q2 25
$109.8M
$379.7M
Q1 25
$113.4M
$365.0M
Q4 24
$118.5M
$344.6M
Q3 24
$76.1M
$311.4M
Q2 24
$111.1M
$292.2M
Gross Margin
RBA
RBA
RMD
RMD
Q2 26
61.8%
Q4 25
61.8%
Q3 25
61.5%
Q2 25
60.8%
Q1 25
59.3%
Q4 24
58.6%
Q3 24
58.6%
Q2 24
58.5%
Operating Margin
RBA
RBA
RMD
RMD
Q2 26
34.6%
Q4 25
14.7%
34.6%
Q3 25
14.5%
33.4%
Q2 25
15.9%
33.7%
Q1 25
17.1%
33.0%
Q4 24
18.1%
32.5%
Q3 24
15.6%
31.6%
Q2 24
18.4%
31.2%
Net Margin
RBA
RBA
RMD
RMD
Q2 26
27.6%
Q4 25
9.1%
27.6%
Q3 25
8.7%
26.1%
Q2 25
9.3%
28.2%
Q1 25
10.2%
28.3%
Q4 24
10.4%
26.9%
Q3 24
7.8%
25.4%
Q2 24
10.1%
23.9%
EPS (diluted)
RBA
RBA
RMD
RMD
Q2 26
$2.68
Q4 25
$0.53
$2.68
Q3 25
$0.43
$2.37
Q2 25
$0.53
$2.58
Q1 25
$0.55
$2.48
Q4 24
$0.58
$2.34
Q3 24
$0.36
$2.11
Q2 24
$0.54
$1.97

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
RBA
RBA
RMD
RMD
Cash + ST InvestmentsLiquidity on hand
$531.5M
$1.4B
Total DebtLower is stronger
$2.3B
$663.8M
Stockholders' EquityBook value
$5.6B
$6.3B
Total Assets
$12.1B
$8.5B
Debt / EquityLower = less leverage
0.42×
0.11×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
RBA
RBA
RMD
RMD
Q2 26
$1.4B
Q4 25
$531.5M
$1.4B
Q3 25
$674.7M
$1.4B
Q2 25
$710.2M
$1.2B
Q1 25
$578.1M
$932.7M
Q4 24
$533.9M
$521.9M
Q3 24
$650.7M
$426.4M
Q2 24
$599.5M
$238.4M
Total Debt
RBA
RBA
RMD
RMD
Q2 26
$663.8M
Q4 25
$2.3B
$403.9M
Q3 25
$2.6B
$408.7M
Q2 25
$2.6B
$658.4M
Q1 25
$2.6B
$663.1M
Q4 24
$2.6B
$662.9M
Q3 24
$2.7B
$667.6M
Q2 24
$2.8B
$697.3M
Stockholders' Equity
RBA
RBA
RMD
RMD
Q2 26
$6.3B
Q4 25
$5.6B
$6.3B
Q3 25
$5.5B
$6.1B
Q2 25
$5.5B
$6.0B
Q1 25
$5.3B
$5.5B
Q4 24
$5.2B
$5.3B
Q3 24
$5.2B
$5.2B
Q2 24
$5.2B
$4.9B
Total Assets
RBA
RBA
RMD
RMD
Q2 26
$8.5B
Q4 25
$12.1B
$8.5B
Q3 25
$12.2B
$8.3B
Q2 25
$12.2B
$8.2B
Q1 25
$11.9B
$7.6B
Q4 24
$11.8B
$7.1B
Q3 24
$11.9B
$7.2B
Q2 24
$12.1B
$6.9B
Debt / Equity
RBA
RBA
RMD
RMD
Q2 26
0.11×
Q4 25
0.42×
0.06×
Q3 25
0.47×
0.07×
Q2 25
0.47×
0.11×
Q1 25
0.50×
0.12×
Q4 24
0.50×
0.13×
Q3 24
0.52×
0.13×
Q2 24
0.55×
0.14×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
RBA
RBA
RMD
RMD
Operating Cash FlowLast quarter
$255.2M
Free Cash FlowOCF − Capex
$186.5M
FCF MarginFCF / Revenue
15.5%
Capex IntensityCapex / Revenue
5.7%
Cash ConversionOCF / Net Profit
2.33×
TTM Free Cash FlowTrailing 4 quarters
$719.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
RBA
RBA
RMD
RMD
Q2 26
Q4 25
$255.2M
$339.7M
Q3 25
$239.7M
$457.3M
Q2 25
$326.5M
$538.8M
Q1 25
$156.8M
$578.7M
Q4 24
$184.5M
$308.6M
Q3 24
$285.4M
$325.5M
Q2 24
$337.3M
$440.1M
Free Cash Flow
RBA
RBA
RMD
RMD
Q2 26
Q4 25
$186.5M
$311.2M
Q3 25
$188.5M
$414.4M
Q2 25
$241.7M
$508.2M
Q1 25
$102.5M
$557.9M
Q4 24
$127.9M
$288.0M
Q3 24
$248.5M
$307.7M
Q2 24
$308.6M
$415.2M
FCF Margin
RBA
RBA
RMD
RMD
Q2 26
Q4 25
15.5%
21.9%
Q3 25
17.3%
31.0%
Q2 25
20.4%
37.7%
Q1 25
9.2%
43.2%
Q4 24
11.2%
22.5%
Q3 24
25.3%
25.1%
Q2 24
28.2%
33.9%
Capex Intensity
RBA
RBA
RMD
RMD
Q2 26
Q4 25
5.7%
2.0%
Q3 25
4.7%
3.2%
Q2 25
7.2%
2.3%
Q1 25
4.9%
1.6%
Q4 24
5.0%
1.6%
Q3 24
3.8%
1.5%
Q2 24
2.6%
2.0%
Cash Conversion
RBA
RBA
RMD
RMD
Q2 26
Q4 25
2.33×
0.87×
Q3 25
2.51×
1.31×
Q2 25
2.97×
1.42×
Q1 25
1.38×
1.59×
Q4 24
1.56×
0.90×
Q3 24
3.75×
1.05×
Q2 24
3.04×
1.51×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

RBA
RBA

Buyer Revenue$577.2M48%
Seller Revenue$255.2M21%
CA$199.0M17%
Other$124.7M10%
AU$47.3M4%

RMD
RMD

Segment breakdown not available.

Related Comparisons